References
- Vanhoutte P. M. Endothelium and control of vascular function. Hypertension 1989; 13: 658–667
- Shepherd J. T., Katsusic Z. S. Endothelium-derived vasoactive factors: I. Endothelium-dependent relaxation. Hypertension 1991; 18(Suppl III)III-76–III-85
- Lockette W., Otsuka Y., Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8(Suppl. II)II-61–II-66
- Luscher T. F., Vanhoutte P. M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8: 344–348
- Panza J. A., Arshed A., Brush J. E., Jr, Epstein S. E. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 1990; 323: 22–27
- Bossaller C., Habib G. B., Yamamoto H., Williams C., Wells S., Henry P. D. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79: 170–174
- McVeigh G. E., Brennan G. M., Johnston G. D., McDermott B. J., McGrath L. T., Henry W. R., Andrews J. W., Hayes J. R. Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 771–776
- Rees D. D., Palmer R. M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 1989; 86: 3375–3378
- Rees D. D., Palmer R. J.J., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro, in vivo. Br. J. Pharmacol. 1990; 101: 746–752
- Gardiner S. M., Compton A. M., Bennett T., Palmer R. J.J., Moncada S. Regional hemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattelboro rats. Br. J. Pharmacol. 1990; 101: 10–12
- Deng L. Y., Schiffrin E. L. Morphological and functional alterations of mesenteric small resistance arteries in early renal hypertension in the rat. Am. J. Physiol. 1991; 261: H1171–H1177
- Deng L. Y., Schiffrin E. L. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am. J. Physiol. 1992; 262: H1782–H1787
- Mulvany M. J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 1977; 41: 19–26
- Mulvany M. J., Hansen P. K., Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and in increased number of smooth muscle cell layers. Circ. Res. 1978; 43: 854–864
- Harper J. F., Brooker G. J. Femtomole sensitive radioimmunoassay from cyclic AMP and cyclic GMP after 2'O acetylation by acetic anhydride in aqueous solution. Cylic Nucleotide Res. 1975; 1: 207–218
- Richman R. A., Kopf G. S., Hamet P., Johnson R. A. Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates. J. Cyclic Nucleotide Res. 1980; 6: 461–468
- Schiffrin E. L., Parent A., St-Louis J., Tremblay J., Garcia R., Thibault G. Vascular atrial natriuretic peptide receptors in spontaneously hypertensive rats. Cardiovasc. Res. 1992; 26: 857–864
- Schiffrin E. L., Thome F. S., Genest J. Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats. Hypertension 1983; 5(Suppl. V)V-16–V-21
- Schiffrin E. L., Thibault G. Plasma endothelin in human essential hypertension. Am. J. Hypertension 1991; 4: 303–308
- Griffin S. A., Brown W. C.B., Macpherson F., McGrath J. C., Wilson V. G., Korsgaard N., Mulvany M. J., Lever A. F. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17: 626–635
- Deng L. Y., Schiffrin E. L. Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats. Am. J. Hypertension 1992, in press
- Dohi Y., Thiel M. A., Buhler F. R., Luscher T. F. Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension 1990; 15: 170–179
- Lahera V., Salom M. G., Miranda F., Moncada S., Romero J. C. Effects of N-Nitro-L-Arginine methylester on renal function and blood pressure. Am. J. Physiol. 1991; 261: F1033–F1037
- Salazar F. J., Pinilla J. M., Lopez F., Romero J. C., Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 1992; 20: 113–117
- Vidal M., Romero J. C., Vanhoutte P. M. Endothelium-derived relaxing factor inhibits renin release. Eur. J. Pharmacol. 1988; 149: 401–402
- Aalkjaer C., Heagerty A. M., Petersen K. K., Swales J. D., Mulvany M. J. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ. Res. 1987; 61: 181–186
- Schiffrin E. L., Deng L. Y., Larochelle P. J. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J. Hypertension 1992; 10: 437–444
- Flückiger J. P., Nguyen P. V., Li G., Yang X. P., Schiffrin E. L. Calcium, phosphoinositide and 1,2 diacylglycerol responses of blood vessels of DOCA-salt hypertensive rats to endothelin-1. Hypertension 1992; 19: 743–748